KB Financial Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 9,691 shares of the exchange traded fund’s stock, valued at approximately $739,000.
A number of other institutional investors have also recently made changes to their positions in the stock. Blue Door Asset Management LLC bought a new stake in SPDR S&P Biotech ETF in the 1st quarter worth approximately $2,134,000. Scotia Capital Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 1.1% in the first quarter. Scotia Capital Inc. now owns 39,734 shares of the exchange traded fund’s stock worth $3,028,000 after buying an additional 446 shares during the period. Pettinga Financial Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 5.3% in the 1st quarter. Pettinga Financial Advisors LLC now owns 19,210 shares of the exchange traded fund’s stock valued at $1,464,000 after acquiring an additional 960 shares during the last quarter. Money Concepts Capital Corp grew its position in SPDR S&P Biotech ETF by 1,043.9% during the 1st quarter. Money Concepts Capital Corp now owns 70,832 shares of the exchange traded fund’s stock worth $1,393,000 after acquiring an additional 64,640 shares during the last quarter. Finally, Ascendant Capital Management LLC purchased a new position in SPDR S&P Biotech ETF in the 4th quarter worth approximately $1,038,000.
SPDR S&P Biotech ETF Stock Performance
Shares of XBI stock opened at $79.13 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $72.44 and a fifty-two week high of $92.60. The company has a market capitalization of $6.07 billion, a P/E ratio of 11.47 and a beta of 0.97. The stock has a 50 day moving average price of $81.16 and a two-hundred day moving average price of $81.77.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
- Five stocks we like better than SPDR S&P Biotech ETF
- Roth IRA Calculator: Calculate Your Potential Returns
- Ray Dalio’s Move into 3 Stocks, All Betting on One Thing
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Airbnb Joins the S&P 500, Time to Buy In?
- What Makes a Stock a Good Dividend Stock?
- Does Dell Technologies Blowout Quarter Mean a New Demand Cycle?
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.